- Home
- ANIP vs NX Comparison
ANIP vs NX Comparison
Compare ANIP & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- NX
- Stock Information
- Founded
- ANIP 2001
- NX 1927
- Country
- ANIP United States
- NX United States
- Employees
- ANIP N/A
- NX N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- NX Metal Fabrications
- Sector
- ANIP Health Care
- NX Industrials
- Exchange
- ANIP Nasdaq
- NX Nasdaq
- Market Cap
- ANIP 1.2B
- NX 1.1B
- IPO Year
- ANIP N/A
- NX N/A
- Fundamental
- Price
- ANIP $61.52
- NX $19.18
- Analyst Decision
- ANIP Buy
- NX Strong Buy
- Analyst Count
- ANIP 8
- NX 1
- Target Price
- ANIP $79.71
- NX $38.00
- AVG Volume (30 Days)
- ANIP 275.5K
- NX 543.0K
- Earning Date
- ANIP 05-09-2025
- NX 03-10-2025
- Dividend Yield
- ANIP N/A
- NX 1.72%
- EPS Growth
- ANIP N/A
- NX N/A
- EPS
- ANIP N/A
- NX 0.29
- Revenue
- ANIP $614,376,000.00
- NX $1,438,751,000.00
- Revenue This Year
- ANIP $26.80
- NX $49.00
- Revenue Next Year
- ANIP $6.89
- NX $2.89
- P/E Ratio
- ANIP N/A
- NX $64.24
- Revenue Growth
- ANIP 26.20
- NX 29.87
- 52 Week Low
- ANIP $52.50
- NX $18.14
- 52 Week High
- ANIP $70.81
- NX $39.31
- Technical
- Relative Strength Index (RSI)
- ANIP 60.64
- NX 36.14
- Support Level
- ANIP $57.72
- NX $18.14
- Resistance Level
- ANIP $64.43
- NX $21.51
- Average True Range (ATR)
- ANIP 2.77
- NX 1.00
- MACD
- ANIP 0.50
- NX -0.00
- Stochastic Oscillator
- ANIP 86.50
- NX 15.43
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its three operating segments are North American Fenestration being the key revenue driver, European Fenestration, and North American Cabinet Components. Geographically, it derives a majority of revenue from the United States.